10021102

Bob cell line human

Manufacturer: Sigma Aldrich

Select a Size

Pack Size SKU Availability Price
1 VIAL 10021102-1-VIAL In Stock ₹ 1,00,455.00

10021102 - 1 VIAL

₹ 1,00,455.00

In Stock

Quantity

1

Base Price: ₹ 1,00,455.00

GST (18%): ₹ 18,081.90

Total Price: ₹ 1,18,536.90

biological source

human prostate

Quality Level

100

form

liquid

growth mode

Adherent

karyotype

4n (81 to 94)

morphology

Cobblestone

products

10% 3-D sphere formation in Matrigel. Migratory and invasive when compared to benign prostate tumour.

receptors

CD44, alpha2 integrin, alpha6 integrin, EGFR, FGFR1, LIFR

technique(s)

cell culture | mammalian: suitable

relevant disease(s)

cancer

Related Products

Img

Sigma Aldrich

10021101

--

Img

Sigma Aldrich

11012007

--

Img

Sigma Aldrich

11012008

--

Img

Sigma Aldrich

94060901

--

Img

Sigma Aldrich

10112301

--

Img

Sigma Aldrich

R8812N-10

--

Description

  • Cell Line Origin: Human prostate cancer spontaneously immortalized, serum-free
  • Cell Line Description: First spontaneously immortalized prostate cancer cell line to be established from a trans-rectal needle biopsy (TRBP) of a patient with castration-resistant prostate cancer (CRPC). Bob is a novel pre-clinical model for functional studies in CRPC and especially for studying the CRPC "basal" phenotype. This cell line is cultured in serum-free culture medium, a derivative of Bob is also available i.e. SerBob, Sigma Catalogue number 10021101, which has been adapted to medium containing serum. SerBob is more differentiated and invasive than Bob. The Y chromosome could not be detected in this cell line by short tandem repeat (STR)-PCR analysis when tested at ECACC. It is a known phenomenon that due to the increased genetic instability of cancer cell lines the Y chromosome can be rearranged or lost resulting in lack of detection. The cell line is identical to the source provided by the depositor based on the STR-PCR analysis.
  • Application: For complete product information, please see ECACC
  • DNA Profile: STR-PCR Data: Amelogenin: X CSF1PO: 11,12 D13S317: 9,14 D16S539: 10,12 D5S818: 13 D7S820: 10,11 THO1: 9 TPOX: 8,10 vWA: 17
  • Culture Medium: Keratinocyte-SFM supplied with prequalified human recombinant epidermal growth factor 1-53 (EGF 1-53), bovine pituitary extract (BPE) and glutamine) + 2ng/ml leukaemia inhibitory factor, 2ng/ml stem cell factor + 100ng/ml cholera toxin + 1ng/ml granulocyte macrophage colony stimulating factor.
  • Subculture Routine: Split sub-confluent cultures (70-80%) 1:5 to 1:20 i.e. seeding at 2-4 x 104 cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37°C. Cells must be centrifuged at 400 x g for 5 minutes to remove the trypsin at each subculture. Cells are cryopreserved in 45% conditioned media: 45% fresh media: 10% DMSO. At confluence 5-7 x 104 cells/cm2 can be expected.
  • Other Notes: Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
  • Disclaimer: RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

SAFETY INFORMATION

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Compare Similar Items

Show Difference

Img

Sigma Aldrich

10021102

--


biological source:
human prostate

Quality Level:
100

form:
liquid

growth mode:
Adherent

karyotype:
4n (81 to 94)

morphology:
Cobblestone

products:
10% 3-D sphere formation in Matrigel. Migratory and invasive when compared to benign prostate tumour.

receptors:
CD44, alpha2 integrin, alpha6 integrin, EGFR, FGFR1, LIFR

technique(s):
cell culture | mammalian: suitable

relevant disease(s):
cancer

Img

Sigma Aldrich

100242

98%...


biological source:
__

Quality Level:
200

form:
solid

growth mode:
__

karyotype:
__

morphology:
__

products:
__

receptors:
__

technique(s):
__

relevant disease(s):
__

Img

Sigma Aldrich

1002505

United States Pharmacopeia (USP) Re...


biological source:
__

Quality Level:
__

form:
__

growth mode:
__

karyotype:
__

morphology:
__

products:
__

receptors:
__

technique(s):
__

relevant disease(s):
__

Img

Sigma Aldrich

100277

≥99%...


biological source:
__

Quality Level:
100

form:
solid

growth mode:
__

karyotype:
__

morphology:
__

products:
__

receptors:
__

technique(s):
__

relevant disease(s):
__